kentucky glp-1 side effect class action Patients Are Suing Over Alleged Effects of Weight-Loss Drugs Ozempic Lawyer in Kentucky |
Description
Harvard geneticist David Sinclair reveals a rare but serious blindness risk linked to GLP-1 drugs, estimating 20,00030,000 NAION cases per year in
The Gallup Poll found that overall, use of semaglutide medicines or liraglutides doubled from nearly 6% in the first quarter of 2024 to over 12% in Q2 + Q3 in 2025
Heres what could take place instead.
India Issues Urgent GLP-1 Drug Safety Alert The Indian Pharmacopoeia Commission (IPC) has issued a public notice on 14 May calling on doctors, patients, and consumers to closely monitor and report any adverse reactions linked to semaglutide and other GLP-1 receptor agonists including dulaglutide, liraglutide, and tirzepatide
Discover its potential benefits
Intima media thickness decreased statistically non-significantly by the GLP-1 based therapies
